SODIUM FLUORIDE F-18
Post-LOEANDAINTRAVENOUSINJECTABLE
Approved
Dec 2012
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SODIUM FLUORIDE F-18 by Sofie is 18 ion normally accumulates in the skeleton in an even fashion, with greater deposition in the axial skeleton (e. First approved in 2012.
Drug data last refreshed 5h ago
Mechanism of Action
18 ion normally accumulates in the skeleton in an even fashion, with greater deposition in the axial skeleton (e.g. vertebrae and pelvis) than in the appendicular skeleton and greater deposition in the bones around joints than in the shafts of long bones.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Sofie
VA - Dulles
Worked on SODIUM FLUORIDE F-18 at Sofie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.